These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28768535)

  • 1. Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel.
    Reinhard-Rupp J; Klohe K
    Infect Dis Poverty; 2017 Aug; 6(1):122. PubMed ID: 28768535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of pediatric schistosomiasis in hard-to-reach areas and populations: A scoping review protocol.
    Isaiah PM; Palmeirim MS; Steinmann P
    F1000Res; 2022; 11():1203. PubMed ID: 36761831
    [No Abstract]   [Full Text] [Related]  

  • 3. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the WHO dose pole in the Philippines for school-based mass drug administration of praziquantel for morbidity control of schistosomiasis.
    Erfe JM; Belizario VY; Chua PL; Naig JR
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):620-6. PubMed ID: 23986489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing policy and practice in the control of pediatric schistosomiasis.
    Mutapi F
    Pediatrics; 2015 Mar; 135(3):536-44. PubMed ID: 25687146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric schistosomiasis: last mile preparations for deploying paediatric praziquantel.
    Mutapi F; Garba A; Woolhouse M; Kazyoba P
    Trends Parasitol; 2024 Aug; 40(8):687-695. PubMed ID: 39033047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting a GRiPP on everyday schistosomiasis: experience from Zimbabwe.
    Mutapi F
    Parasitology; 2017 Oct; 144(12):1624-1632. PubMed ID: 27729092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-wide treatment of schistosomiasis with praziquantel.
    Webbe G
    Trop Doct; 1999 Jul; 29(3):172-6. PubMed ID: 10448248
    [No Abstract]   [Full Text] [Related]  

  • 9. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis: number of people treated worldwide in 2014.
    Wkly Epidemiol Rec; 2016 Feb; 91(5):53-60. PubMed ID: 26852429
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the Gabon.
    Burchard GD; Kern P; Baltes R; Dietrich M
    Tropenmed Parasitol; 1984 Jun; 35(2):91-4. PubMed ID: 6464191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads.
    Panic G; Keiser J
    Curr Opin Pharmacol; 2018 Oct; 42():27-33. PubMed ID: 30077117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putting the treatment of paediatric schistosomiasis into context.
    Mduluza T; Mutapi F
    Infect Dis Poverty; 2017 Apr; 6(1):85. PubMed ID: 28388940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosomiasis drug therapy and treatment considerations.
    Shekhar KC
    Drugs; 1991 Sep; 42(3):379-405. PubMed ID: 1720380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of NTDs Drug-discovery Research Consortium].
    Namatame I
    Yakugaku Zasshi; 2016; 136(2):231-6. PubMed ID: 26831798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium).
    Kern P; Burchard GD; Dietrich M
    Tropenmed Parasitol; 1984 Jun; 35(2):95-9. PubMed ID: 6464192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study on hepatosplenomegalic schistosomiasis japonica on Leyte Island: follow-up study 4 years after treatment with praziquantel.
    Hayashi M; Matsuda H; Tormis LC; Noseñas JS; Blas BL
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):498-501. PubMed ID: 6535265
    [No Abstract]   [Full Text] [Related]  

  • 18. Sociocultural aspects of mass delivery of praziquantel in schistosomiasis control: the Abeokuta experience.
    Adeneye AK; Akinwale OP; Idowu ET; Adewale B; Manafa OU; Sulyman MA; Omotola BD; Akande DO; Mafe MA; Appelt B
    Res Social Adm Pharm; 2007 Jun; 3(2):183-98. PubMed ID: 17561219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience.
    Chen MG
    Acta Trop; 2005; 96(2-3):168-76. PubMed ID: 16125657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical dosing of praziquantel for schistosomiasis in preschool-aged children.
    Olliaro PL; Vaillant M; Hayes DJ; Montresor A; Chitsulo L
    Trop Med Int Health; 2013 Sep; 18(9):1085-1089. PubMed ID: 23937700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.